Private equity firms Carlyle and Nadathur Fareast-backed Indegene, which provides digital led commercialisation services for the life sciences industry, has set a price band of Rs 430-452 a share for its Rs 1,842- crore IPO that opens for subscription on May 6. The firm plans to raise Rs 760 crore through fresh issue, while holders will offer shares worth around Rs 1,081.75 crore, taking the issue size to Rs 1,842 crore. Catch Nandita Khemka in conversation with Manish Gupta Chairman & CEO of Indegene on the fund raise, and the company’s growth and expansion plans. #ipo#live #sensex #indegene Moneycontrol is India's leading financial and business portal with in-depth market coverage, analysis, expert opinions, and a gamut of financial tools. A part of Network18, moneycontrol.com is the most influential destination for stock market news and advice, business news, and news about the Indian and global economy. Subscribe: https://bit.ly/moneycontrolyoutube Follow us: Visit https://www.moneycontrol.com/ Facebook: https://www.facebook.com/moneycontrol/ Twitter: http://www.twitter.com/moneycontrolcom Instagram: https://www.instagram.com/moneycontrolcom/